Preprint Review Version 1 This version is not peer-reviewed

Effects of E-cigarettes on Physiological Pathways and Proposed Therapeutic Intervention with Bixin

Version 1 : Received: 1 November 2024 / Approved: 5 November 2024 / Online: 5 November 2024 (15:30:23 CET)

How to cite: Claymore, S.; Allen-Gipson, D. Effects of E-cigarettes on Physiological Pathways and Proposed Therapeutic Intervention with Bixin. Preprints 2024, 2024110349. https://doi.org/10.20944/preprints202411.0349.v1 Claymore, S.; Allen-Gipson, D. Effects of E-cigarettes on Physiological Pathways and Proposed Therapeutic Intervention with Bixin. Preprints 2024, 2024110349. https://doi.org/10.20944/preprints202411.0349.v1

Abstract

Electronic cigarettes (e-cigs) have increased in popularity and usage over the last few decades. While e-cigs were originally introduced as a healthy alternative to cigarette smoking, recent research has demonstrated the cytotoxic effects of nicotinic e-cig devices[1]. E-cigs cause damage on multiple cell types, including epithelial and endothelial cells, along with causing dysregulation of inflammatory pathways. This review will discuss the harmful effects of e-cigs on the human body, highlighting the physiological effects of e-cigs on pulmonary, cardiovascular, and cerebrovascular health.

Moreover, this review will highlight the potential therapeutic effects of bixin, an apocarotenoid found in the seeds of Bixa orellana, also known as the achiote tree. Bixin has innate anti-inflammatory, antioxidant, and anti-cancer activities that have been demonstrated in recent research. Nanotechnology has surfaced in the past few decades as a powerful tool for medicinal practice. Specifically, nanoparticles serve as a potential method for treating a wide variety of conditions and diseases. Bixin nanoparticles show promise as a viable method for the treatment of e-cig induced damage due to the innate properties of bixin along with the advantages of using nanoparticles compared to conventional medicinal interventions.

Keywords

E-cig; Bixin; nanoparticles; inflammation

Subject

Medicine and Pharmacology, Pulmonary and Respiratory Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.